GlassScriptPhysician profile
Anna Noukchipon Tomdio
NPI 1407202070
$5,448.84
in general payments reported to CMS, 2019-2025
34 companies · $1,342 in 2025
The $1,342 reported for 2025 was more than what 76% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $155 · 2022: $214 · 2023: $1,115 · 2024: $2,623 · 2025: $1,342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,917 · Travel and Lodging: $163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,917.11 |
| Travel and Lodging | $162.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $864.17 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $811.99 | 2022-2025 | Coroflow, Diamondback Coronary, Thoratec Heartmate 3 Lvas Implant Kit |
| Philips North America LLC | $550.92 | 2021-2025 | Coronary Other, (P84) Igt Devices Systems, (5044) Mcot |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $506.86 | 2024-2025 | Lifevest |
| Boston Scientific Corporation | $410.84 | 2023-2025 | Avvigo Guidance System, Watchman Access System, Watchman Flx |
| Abiomed | $348.17 | 2023-2024 | Impella |
| Novartis Pharmaceuticals Corporation | $273.22 | 2023-2025 | |
| Medtronic, INC. | $178.33 | 2023-2025 | Symplicity G3, Na, Ffrangio |
| Heartflow, INC. | $172.61 | 2023-2024 | Ffrct |
| Irhythm Technologies, INC. | $165.92 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Astrazeneca Pharmaceuticals LP | $158.95 | 2023-2025 | Farxiga, Lokelma, Andexxa |
| Amgen INC. | $101.91 | 2023-2025 | Repatha, Repatha |
| Scpharmaceuticals INC. | $99.44 | 2024-2025 | |
| Kiniksa Pharmaceuticals, LTD. | $94.64 | 2021 | |
| Medicomp INC | $76.26 | 2024 | Telepatch Cardiac Monitor |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $74.06 | 2024-2025 | Camzyos |
| Atricure, INC. | $64.57 | 2024-2025 | Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Pfizer INC. | $63.15 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $45.67 | 2024 | Xarelto |
| Baxter Healthcare | $40.51 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Cvrx, INC. | $37.78 | 2025 | Barostim Neo System |
| Kestra Medical Technology Services, INC. | $36.97 | 2024-2025 | Assure Wcd |
| Cordis US Corp. | $36.19 | 2024 | Mynx Venous Vcd, Mynxgrip |
| Biosense Webster, INC. | $32.87 | 2023 | Carto 3 |
| Sanofi-Aventis U.S. LLC | $27.44 | 2023 | |
| Cardiva Medical, INC. | $25.17 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Alnylam Pharmaceuticals INC. | $24.74 | 2025 | Amvuttra |
| Lilly USA, LLC | $22.38 | 2025 | Zepbound |
| Novo Nordisk INC | $21.67 | 2024 | Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $20.10 | 2025 | |
| Terumo Medical Corporation | $16.49 | 2022 | |
| Chiesi USA, INC. | $15.47 | 2023 | Kengreal |
| Inspire Medical Systems, INC. | $15.42 | 2024 | Inspire |
| Merck Sharp & Dohme LLC | $13.96 | 2025 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Tomdio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.